Supports clinical oncology trials in cancer prevention and control in community settings. Funds investigator-initiated research in supportive, palliative and end-of-life care. Coordinates with other NCI programs to conduct clinical oncology research projects in the community setting.
On This Page
- All Heading 2s will automatically be pulled in to this list.
- Do not edit the content on this template.
Major Programs
Staff List
| Photo | Name, Email, Phone | Room | Group(s)/Office |
|---|---|---|---|
 |
Heckman-Stoddard, Brandy, Ph.D., M.P.H. brandy.heckman-stoddard@nih.gov 240-276-7048 |
5E334 | Chief
|
Breast and Gynecologic Cancer
Acting Chief | Community Oncology and Prevention Trials |
 |
Lee, Beverly beverly.lee@nih.gov |
5E532 | Program Officer | Community Oncology and Prevention Trials |
 |
Lee, Cecilia, Dr.P.H., RN cecilia.lee@nih.gov 240-276-7152 |
5E516 | Nurse Consultant | Community Oncology and Prevention Trials |
| Maxwell, Pamela pamela.maxwell@nih.gov 240-276-7081 |
5E434 | Program Specialist | Community Oncology and Prevention Trials | |
 |
McCarty, Larae larae.mccarty@nih.gov 240-276-5777 |
5E322 | Program Specialist
|
Community Oncology and Prevention Trials
Early Detection |
 |
Parker, Bernard, M.D., FACP bernard.parker@nih.gov 240-276-5533 |
5E448 | Program Officer | Community Oncology and Prevention Trials |
 |
Streck, Brennan, Ph.D., RN, M.P.H. brennan.streck@nih.gov 240-276-7050 |
5E430 | Program Officer
|
Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials |
 |
Voss, Alyssa, M.P.H. alyssa.voss@nih.gov 240-204-3107 |
Writer/Editor
|
Office of the Director
Community Oncology and Prevention Trials |
|
 |
White, Vanessa A., M.P.H. vanessa.white@nih.gov 240-276-6163 |
5E524 | Program Officer
|
Breast and Gynecologic Cancer
Program Officer | Community Oncology and Prevention Trials |
Grants
| PI Name | PI Organization | Title Sort descending | Grant Number | Program Official |
|---|---|---|---|---|
| Morilak, David A | University Of Texas Hlth Science Center |
Therapy-induced cognitive impairment in a rat model of prostate cancer | 5R01CA285183-03 | John Clifford, Ph.D. |
| Khasabov, Sergey G | University Of Minnesota |
Treatment of cancer pain by lipid mediator Resolvin D1: role of Prostaglandin and Endocannabinoid signaling | 5R01CA263777-05 | Rachel Altshuler, Ph.D. |
| Cao, Weidan | Ohio State University |
Treatment-Related Cardiotoxicity Risk Prediction for Breast Cancer Patients with a Multimodal AI-based System | 1R01CA301579-01 | Eileen Dimond, R.N., M.S. |
| Rini, Christine | Northwestern University At Chicago |
Web-based Pain Coping Skills Training to Improve Pain and Poor Adherence caused by Aromatase Inhibitor-Associated Arthralgia In Breast Cancer Survivors (SKIP-Arthralgia): A Randomized Controlled Trial | 5R01CA271220-04 | Brennan Streck, Ph.D., RN, M.P.H. |